Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Morris

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
JCO Precision Oncology|July 29, 2021
Comprehensive Breast Cancer Risk Assessment for <i>CHEK2</i> and <i>ATM</i> Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick ModelShannon Gallagher, Elisha Hughes, Allison W Kurian, et al.
Frontiers in Neurology|April 27, 2026
The second decade of DTI in TBI part 1: a systematic review of mild TBIMolly F Charney, Simone Glajchen, Shawn Brain, et al.
BMC Cancer|April 18, 2015
Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer riskThaddeus Judkins, Benoît Leclair, Karla Bowles, et al.
Frontiers in Neurology|February 23, 2026
The second decade of DTI in TBI Part 2: a systematic review of moderate and severe TBIMolly F Charney, Simone Glajchen, Shawn Brain, et al.
Genes, Chromosomes & Cancer|May 24, 2023
The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencingMelanie A Jones, Kirsten M Timms, Shanell Hatcher, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
JCO Precision Oncology|July 29, 2021
Comprehensive Breast Cancer Risk Assessment for <i>CHEK2</i> and <i>ATM</i> Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick ModelShannon Gallagher, Elisha Hughes, Allison W Kurian, et al.
Frontiers in Neurology|April 27, 2026
The second decade of DTI in TBI part 1: a systematic review of mild TBIMolly F Charney, Simone Glajchen, Shawn Brain, et al.
BMC Cancer|April 18, 2015
Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer riskThaddeus Judkins, Benoît Leclair, Karla Bowles, et al.
Frontiers in Neurology|February 23, 2026
The second decade of DTI in TBI Part 2: a systematic review of moderate and severe TBIMolly F Charney, Simone Glajchen, Shawn Brain, et al.
Genes, Chromosomes & Cancer|May 24, 2023
The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencingMelanie A Jones, Kirsten M Timms, Shanell Hatcher, et al.
Pageof 4